Effective? Engaging? Secure? Applying the ORCHA-24 framework to evaluate apps for chronic insomnia disorder Effective? Engaging? Secure? Applying the ORCHA-24 framework to evaluate apps for chronic insomnia disorder | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Effective? Engaging? Secure? Applying the ORCHA-24 framework to evaluate apps for chronic insomnia disorder Article Text Original article Effective? Engaging? Secure? Applying

Eszopiclone for insomnia. BACKGROUND: Insomnia is a major public health issue affecting between 6% to 10% of the adult population in Western countries. Eszopiclone is a hypnotic drug belonging to a newer group of hypnotic agents, known as new generation hypnotics, which was marketed as being just as effective as benzodiazepines for this condition, while being safer and having a lower risk for abuse and dependence. It is the aim of the review to integrate evidence from randomised controlled (...) trials and to draw conclusions on eszopiclone's efficacy and safety profile, while taking methodological features and bias risks into consideration. OBJECTIVES: To assess the efficacy and safety of eszopiclone for the treatment of insomnia compared to placebo or active control. SEARCH METHODS: We searched the Cochrane Central Register of Controlled trials (CENTRAL), MEDLINE, Embase, PsycINFO, PSYNDEX and registry databases (WHO trials portal, ClinicalTrials.gov) with results incorporated from

Melatonin (Slenyto) - insomnia (difficulty sleeping) in children and adolescents (2 to 18 years old) Slenyto | European Medicines Agency Search Search Menu Slenyto melatonin Table of contents Authorised This medicine is authorised for use in the European Union. Overview Slenyto is a medicine for treating insomnia (difficulty sleeping) in children and adolescents (2 to 18 years old) who have: autism spectrum disorder (ASD), a range of conditions that affects the patient’s social interactions (...) of the brain and helping to bring about sleep. Its levels in the blood normally increase after the onset of darkness and peak in the middle of the night. Patients with developmental conditions may produce less melatonin, leading to the development of insomnia. Slenyto increases levels of melatonin in the blood, helping them to sleep. Because Slenyto releases melatonin slowly over a few hours, it mimics the natural production of melatonin in the body. What benefits of Slenyto have been shown in studies

Insomnia Top results for insomnia - Trip Database or use your Google+ account Liberating the literature My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing (...) the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for insomnia The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines

Impact of group treatment for insomnia on daytime symptomatology: Analyses from a randomized controlled trial in primary care 29886347 2018 06 12 1873-491X 85 2018 May 24 International journal of nursing studies Int J Nurs Stud Impact of group treatment for insomnia on daytime symptomatology: Analyses from a randomized controlled trial in primary care. 126-135 S0020-7489(18)30114-7 10.1016/j.ijnurstu.2018.05.002 People typically seek primary health care for daytime symptoms and impairments (...) they experience in association with their insomnia. However, few studies address the question of whether insomnia treatment can improve such symptomatology. To investigate whether a nurse-led group treatment program, based on the techniques of cognitive behavioral therapy for insomnia (CBT-I), improved daytime symptomatology in primary care patients with insomnia. Fatigue (Fatigue Severity Scale [FSS]; main outcome), mood (General Health Questionnaire and Montgomery-Asberg Depression Rating Scale), health

Antidepressants for insomnia in adults. BACKGROUND: Insomnia disorder is a subjective condition of unsatisfactory sleep (e.g. sleep onset, maintenance, early waking, impairment of daytime functioning). Insomnia disorder impairs quality of life and is associated with an increased risk of physical and mental health problems including anxiety, depression, drug and alcohol abuse, and increased health service use. hypnotic medications (e.g. benzodiazepines and 'Z' drugs) are licensed for sleep (...) promotion, but can induce tolerance and dependence, although many people remain on long-term treatment. Antidepressant use for insomnia is widespread, but none is licensed for insomnia and the evidence for their efficacy is unclear. This use of unlicensed medications may be driven by concern over longer-term use of hypnotics and the limited availability of psychological treatments. OBJECTIVES: To assess the effectiveness, safety and tolerability of antidepressants for insomnia in adults. SEARCH METHODS

Insomnia Insomnia - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Insomnia Last reviewed: August 2018 Last updated: April 2018 Summary One of the most common complaints reported in primary care. Unmanaged insomnia can cost over US $100 billion each year due to accidents and poor work productivity. Associated with anxiety, depression, and physical complaints. Diagnosis is made primarily by patient interview. Sleep (...) diaries, actigraphy, and polysomnography may assist in confirming diagnosis. Identification of the correct aetiology is essential, as interventions differ and may be harmful in some cases if the diagnosis is incorrect. Education regarding sleep hygiene techniques is useful to prevent chronic insomnia. The significant morbidity of insomnia indicates that it is a condition that warrants treatment. Definition As per the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), American

Treatments for Insomnia: A Review of Patient and Experiences and Perspectives Treatments for Insomnia: A Review of Patient and Experiences and Perspectives | CADTH.ca Find the information you need Treatments for Insomnia: A Review of Patient and Experiences and Perspectives Treatments for Insomnia: A Review of Patient and Experiences and Perspectives Published on: September 27, 2017 Project Number: RD0039-000 Product Line: Research Type: Drug Report Type: Peer-reviewed summary with critical (...) appraisal Result type: Report Question What are patient, caregiver, or family member experiences with and perspectives of treatment and management of insomnia? Key Message Only patient perceptions were available for review, there were no relevant data on caregiver or family member experiences. Patients’ perceptions of and engagements with pharmacotherapy tend to vary in relation to nightly levels of fatigue, daytime responsibilities and social normalization of medical sleeping aids. While the duration

Trajectories of change and long-term outcomes in a randomised controlled trial of internet-based insomnia treatment to prevent depression 28959453 2018 11 13 2056-4724 3 5 2017 Sep BJPsych open BJPsych Open Trajectories of change and long-term outcomes in a randomised controlled trial of internet-based insomnia treatment to prevent depression. 228-235 10.1192/bjpo.bp.117.005231 Insomnia treatment using an internet-based cognitive-behavioural therapy for insomnia (CBT-I) program reduces (...) program. Adults ( N =1149) with clinical insomnia and subclinical depression symptoms were recruited online from the Australian community. Depression, anxiety and insomnia decreased significantly by week 4 of the intervention period and remained significantly lower relative to control for >18 months (between-group Cohen's d =0.63, 0.47, 0.55, respectively, at 18 months). Effects on suicidal ideation were only short term. Two depression trajectories were identified using growth mixture models

Management of Insomnia Disorder in Adults: Current State of the Evidence Management of Insomnia Disorder in Adults: Current State of the Evidence Focus of This Summary This is a summary of a systematic review that evaluated current evidence regarding the effectiveness, comparative effectiveness, and adverse effects of management strategies for insomnia disorder in adults. The systematic review synthesized evidence from 169 randomized controlled trials and 12 observational studies published (...) through January 2015. The full report, listing all studies, is available at www.effectivehealthcare.ahrq.gov/insomnia/. This summary is provided to assist in informed clinical decisionmaking. However, reviews of evidence should not be construed to represent clinical recommendations or guidelines. Background Insomnia involves dissatisfaction with sleep quantity or quality and is associated with difficulty initiating sleep, maintaining sleep, returning to sleep after early morning waking

Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series 28765835 2018 11 13 2373-8057 3 2017 NPJ Parkinson's disease NPJ Parkinsons Dis Cognitive behavioral therapy for insomnia in Parkinson's disease: a case series. 25 10.1038/s41531-017-0027-z Chronic insomnia is common in patients with Parkinson's disease. There are limited data to guide its treatment in this patient population, especially in regards to non-pharmacologic interventions, some of which are highly (...) effective in the non-Parkinson's disease population. The aim of this study is to describe a series of Parkinson's disease patients who underwent cognitive behavioral therapy for insomnia (CBTi). Parkinson's disease patients who had undergone a baseline and at least one follow-up CBTi session were identified. Electronic medical records and pre-treatment and post-treatment patient sleep diaries were reviewed. Sleep measures of interest included wake time after sleep onset, sleep efficiency, sleep onset

Tai Chi Chih Compared With Cognitive Behavioral Therapy for the Treatment of Insomnia in Survivors of Breast Cancer: A Randomized, Partially Blinded, Noninferiority Trial 28489508 2017 05 10 2017 05 10 1527-7755 2017 May 10 Journal of clinical oncology : official journal of the American Society of Clinical Oncology J. Clin. Oncol. Tai Chi Chih Compared With Cognitive Behavioral Therapy for the Treatment of Insomnia in Survivors of Breast Cancer: A Randomized, Partially Blinded, Noninferiority (...) Trial. JCO2016710285 10.1200/JCO.2016.71.0285 Purpose Cognitive behavioral therapy for insomnia (CBT-I) and Tai Chi Chih (TCC), a movement meditation, improve insomnia symptoms. Here, we evaluated whether TCC is noninferior to CBT-I for the treatment of insomnia in survivors of breast cancer. Patients and Methods This was a randomized, partially blinded, noninferiority trial that involved survivors of breast cancer with insomnia who were recruited from the Los Angeles community from April 2008

Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical Effectiveness and Guidelines Medical Cannabis or Cannabinoids for the Treatment of Insomnia Disorder in Adults: Clinical (...) Effectiveness and Guidelines Published on: June 26, 2017 Project Number: RB1113-000 Product Line: Research Type: Drug Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of medical cannabis or cannabinoids for the treatment of insomnia disorder in adults? What are the evidence-based guidelines regarding the use of medical cannabis or cannabinoids for the treatment of insomnia disorder in adults? Key Message One non-randomized study was identified regarding

Current Practice Analysis: Interventions for Insomnia Disorder Current Practice Analysis: Interventions for Insomnia Disorder | CADTH.ca CADTH Document Viewer Current Practice Analysis: Interventions for Insomnia Disorder Table of Contents Search this document Current Practice Analysis: Interventions for Insomnia Disorder June 2017 Introduction CADTH studied the use of interventions to treat insomnia disorder (acute and chronic) in Canadian primary care practice. The study investigated current (...) practices and trends in drug and non-drug therapies for patients with insomnia disorder from the perspective of family physicians, nurse practitioners, and pharmacists. The findings are based on a targeted literature review as well as on the results of qualitative research from surveys of primary care practitioners. This report presents a summary of findings. Issue Insomnia disorder is a common complaint in the primary care setting. 1 The most common symptoms of insomnia are difficulty in initiating

Current Practice Analysis: Interventions for Insomnia Disorder Current Practice Analysis: Interventions for Insomnia Disorder | CADTH.ca CADTH Document Viewer Current Practice Analysis: Interventions for Insomnia Disorder Table of Contents Search this document Current Practice Analysis: Interventions for Insomnia Disorder June 2017 Introduction CADTH studied the use of interventions to treat insomnia disorder (acute and chronic) in Canadian primary care practice. The study investigated current (...) practices and trends in drug and non-drug therapies for patients with insomnia disorder from the perspective of family physicians, nurse practitioners, and pharmacists. The findings are based on a targeted literature review as well as on the results of qualitative research from surveys of primary care practitioners. This report presents a summary of findings. Issue Insomnia disorder is a common complaint in the primary care setting. 1 The most common symptoms of insomnia are difficulty in initiating

Insomnia and somnolence in idiopathic RBD: a prospective cohort study 28649609 2018 11 13 2373-8057 3 2017 NPJ Parkinson's disease NPJ Parkinsons Dis Insomnia and somnolence in idiopathic RBD: a prospective cohort study. 9 10.1038/s41531-017-0011-7 Although some sleep disorders are markers of prodromal Parkinson's disease and dementia with Lewy bodies, it is unclear whether insomnia and somnolence can predict disease. We assessed a large cohort of patients with idiopathic rapid eye movement (...) sleep behavior disorder and age/sex matched controls, comparing the Epworth sleepiness scale, the Insomnia Severity Index, the Pittsburgh Sleep Quality Index, and polysomnographic variables. In those with repeated scales, we assessed change over time. Finally, we assessed whether sleep abnormalities predicted defined neurodegenerative disease. The 151 patients (age = 65.9, 75% male) completed sleep scales and were included. Epworth scores were similar between patients and controls (7.0+/-4.6 vs. 7.2

Appropriate Use of Interventions for Adults With Insomnia Disorder Appropriate Use of Interventions for Adults With Insomnia Disorder | CADTH.ca Find the information you need Appropriate Use of Interventions for Adults With Insomnia Disorder Appropriate Use of Interventions for Adults With Insomnia Disorder Published on: February 23, 2017 Project Number: OP0527 Product Line: Result type: Report Projects listed as “in progress” are at various stages and points of completion. These products have (...) different processes and timelines; therefore, the timing of posting of the final reports varies. The “Projects in Progress” page on the CADTH website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. Insomnia is a sleep disorder affecting approximately 13% of the Canadian population. People with insomnia often have difficulty falling asleep or difficulty remaining asleep. They may also wake

Insomnia. Effective management of insomnia begins with recognition and adequate assessment. Family doctors and other health care providers such as practice nurses and psychologists should routinely enquire about sleep habits as a component of overall health assessment. Identification and treatment of primary psychiatric disorders, medical conditions, circadian disorders, or specific physiological sleep disorders--eg, sleep apnoea and periodic limb movement disorder--are essential steps (...) in management of insomnia. Conditioned aspects of insomnia can be primary (psychophysiological insomnia) or may complicate sleep disturbance owing to other causes. Approved hypnotic drugs have clearly been shown to improve subjective and objective sleep measures in various short-term situations. Despite widespread use of standard hypnotics and sedating antidepressants for chronic insomnia, their role for this indication still remains to be further defined by research evidence. Non-pharmacological treatments

Randomised controlled trial: Cognitive?behavioural therapy for insomnia is effective, safe and highly deployable Cognitive–behavioural therapy for insomnia is effective, safe and highly deployable | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Cognitive–behavioural therapy for insomnia is effective, safe and highly deployable Article Text Care of the older person Randomised controlled trial Cognitive–behavioural therapy for insomnia is effective, safe and highly deployable Michael V Vitiello Statistics from Altmetric.com Commentary on: Alessi C , Martin JL

Cognitive behavioural therapy for chronic insomnia RACGP - Cognitive behavioural therapy for chronic insomnia Username Password Password security changes or call 1800 284 789 Search the RACGP website Your browser has 'Cookies' disabled, alert boxes will continue to appear without this feature. / / / / / Cognitive behavioural therapy for chronic insomnia HANDI Making non-drug interventions easier to find and use Cognitive behavioural therapy for chronic insomnia Chronic insomnia is the third (...) most common psychological reason for GP consultations – most patients prefer not to take medication to overcome this problem Intervention Cognitive behavioural therapy for insomnia (CBT-i) including the following components: cognitive therapy, stimulus control, sleep restriction, sleep hygiene and relaxation. CBT-i may be delivered face-to-face, digitally or using a combination of both. Indication Chronic insomnia, defined as difficulty either getting to sleep or staying asleep for at least 3